Catalent competitorsClear all

Catalent's top competitors include Aldevron, Vetter Pharma, Eurofins, WuXi Biologics, Regeneron Pharmaceuticals, Gilead Sciences, Bristol-Myers Squibb and Lonza.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Catalent
Catalent
Catalent Pharma Solutions is a company providing integrated services, drug delivery technologies, and manufacturing solutions.
Aldevron
Aldevron
Aldevron is a contract manufacturer providing biological products for research, clinical and diagnostic applications.
Vetter Pharma
Vetter Pharma
Vetter Pharma is a company engaged in the production of aseptically prefilled syringe systems, cartridges, and vials.
Eurofins
Eurofins
Eurofins Scientific is a life sciences company providing laboratory testing services.
WuXi Biologics
WuXi Biologics
WuXi Biologics is a company operating as an open-access technology platform for biologics drug development.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.
Lonza
Lonza
Lonza (also known as Lonza Biologics) is a company that supplies active ingredients, chemical intermediates, and biotechnology solutions to the pharmaceutical and agrochemical industries.
Founding Date
Founding Date
2007
Founding Date
1998
Founding Date
1950
Founding Date
1987
Founding Date
2010
Founding Date
1988
Founding Date
1987
Founding Date
1887
Founding Date
1897
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Franklin Township, US HQ
Loma Hermosa, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
Sorocaba, BR
see more
Locations
Fargo, US HQ
Fargo, US
Madison, US
Locations
Ravensburg, DE HQ
Rankweil, AT
Langenargen, DE
Ravensburg, DE
Ravensburg, DE
Ravensburg, DE
see more
Locations
Luxembourg, LU HQ
Aix En Provence, FR
Aix En Provence, FR
Aix En Provence, FR
Aix En Provence, FR
Aix En Provence, FR
Aix En Provence, FR
see more
Locations
Wuxi, CN HQ
George Town, KY
Hangzhou, CN
Shanghai, CN
Suzhou, CN
Wuxi, CN
Hong Kong, HK
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
Rueil Malmaison, FR
see more
Locations
Basel, CH HQ
Bella Vista, AU
Brooklyn, AU
Derrimut, AU
Mount Waverley, AU
Bornem, BE
Verviers, BE
see more
Employees
Employees
13,90013% increase
Employees
553
Employees
5,50010% increase
Employees
44,7413% increase
Employees
6,64617% increase
Employees
9,12313% increase
Employees
13,60015% increase
Employees
30,00029% increase
Employees
16,5404% increase
Valuation ($)
Valuation ($)
20.4 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
22.9 b
Valuation ($)
N/A
Valuation ($)
61.2 b
Valuation ($)
85.6 b
Valuation ($)
153.1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
18.7 k
Twitter followers
682
Twitter followers
279
Twitter followers
334
Twitter followers
158
Twitter followers
28.8 k
Twitter followers
68.3 k
Twitter followers
152 k
Twitter followers
7.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
111
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
103
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
39
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.7
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
13.7
Average likes per tweet (last 30 days)
109.5
Average likes per tweet (last 30 days)
7.4
Average likes per tweet (last 30 days)
22.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
46.85%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
95.15%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
199109
Alexa Website Rank
236984
Alexa Website Rank
480460
Alexa Website Rank
246102
Alexa Website Rank
432433
Alexa Website Rank
183060
Alexa Website Rank
126222
Alexa Website Rank
168770
Alexa Website Rank
169168
Employee Rating
Employee Rating
3.5
Employee Rating
3.5
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
3.9
Employee Rating
3.8
Employee Rating
4
Employee Rating
3.3

Financial

Revenue (est.)
Revenue (est.)
$3.1b (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
€594.9m (FY, 2018)
Revenue (est.)
€5.4b (FY, 2020)
Revenue (est.)
¥5.6b (FY, 2020)
Revenue (est.)
$8.5b (FY, 2020)
Revenue (est.)
$24.7b (FY, 2020)
Revenue (est.)
$42.5b (FY, 2020)
Revenue (est.)
CHF4.5b (FY, 2020)
Cost of goods
Cost of goods
$2.1b (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€1.7b (FY, 2020)
Cost of goods
¥3.1b (FY, 2020)
Cost of goods
$1.1b (FY, 2020)
Cost of goods
$4.6b (FY, 2020)
Cost of goods
$11.8b (FY, 2020)
Cost of goods
CHF2.7b (FY, 2020)
Gross profit
Gross profit
$983.3m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Gross profit
€3.7b (FY, 2020)
Gross profit
¥2.5b (FY, 2020)
Gross profit
$7.4b (FY, 2020)
Gross profit
$20.1b (FY, 2020)
Gross profit
$30.7b (FY, 2020)
Gross profit
CHF1.8b (FY, 2020)
Net income
Net income
$220.7m (FY, 2020)
Net income
N/A
Net income
N/A
Net income
€540.5m (FY, 2020)
Net income
¥1.7b (FY, 2020)
Net income
$3.5b (FY, 2020)
Net income
$89m (FY, 2020)
Net income
($9b) (FY, 2020)
Net income
CHF871m (FY, 2020)

Operating

Backlog
Backlog
$2.3b (FY, 2020)
Backlog
N/A
Backlog
N/A
Backlog
N/A
Backlog
$11.3b (FY, 2020)
Backlog
N/A
Backlog
N/A
Backlog
N/A
Backlog
N/A
Countries
Countries
85 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
50 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
35 (FY, 2020)
Countries
N/A
Countries
30 (FY, 2019)
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
31 (FY, 2020)
Patents (US)
650 (Dec, 2020)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
19 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
3 (FY, 2020)
Phase II Trials Products (Oncology)
14 (FY, 2019)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
3 (FY, 2020)
Phase III Trials Products (Oncology)
9 (FY, 2019)
Phase III Trials Products (Oncology)
N/A
Products
Products
7 k (FY, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
7 (FY, 2020)
Products
20 (FY, 2020)
Products
N/A
Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Aldevron
HQ
Fargo, US
Employees
553

Aldevron is a contract manufacturer providing biological products for research, clinical and diagnostic applications.

View company
Vetter Pharma
HQ
Ravensburg, DE
Employees
5,500↑ 10% increase

Vetter Pharma is a company engaged in the production of aseptically prefilled syringe systems, cartridges, and vials.

View company
Eurofins
HQ
Luxembourg, LU
Employees
44,741↑ 3% increase

Eurofins Scientific is a life sciences company providing laboratory testing services.

View company
WuXi Biologics
HQ
Wuxi, CN
Employees
6,646↑ 17% increase

WuXi Biologics is a company operating as an open-access technology platform for biologics drug development.

View company